The purpose of this study is to explore the efficacy and safety of an investigational treatment
for everyone with moderate to severe eczema (atopic dermatitis).
Rivipansel is an investigational treatment
for VOC in people with SCD and not approved for use.
Mallinckrodt announced that it is permanently discontinuing its Phase 2B study designed to assess the efficacy and safety of Acthar Gel as an investigational treatment
for amyotrophic lateral sclerosis, or ALS.
New interim data further support safety and efficacy of Biogen and Alkermes' investigational treatment
, diroximel fumarate, to be marketed as VUMERITY[TM] if approved by the FDA
The expansion will include a new building dedicated to Merck biotech medicines destined for more than 150 countries, helping to meet increasing patient requirements for flagship medicines such as fertility treatment Gonal-f, newly launched therapies such as cancer drug Bavencio and potential future products currently in clinical development, including cancer investigational treatment
Purdue Pharma LP, a provider of prescription medicines, revealed on Tuesday that the first patient has been enrolled in a Phase 1 investigator-initiated clinical trial of tinostamustine, an investigational treatment
, in patients with newly-diagnosed common and aggressive type of primary malignant brain tumour, unmethylated O6-Methylguanine-DNA-methyltransferase (MGMT) glioblastoma multiforme (unmethylated nGBM).
As with other anti-cancer treatments, this investigational treatment
may or may not provide benefit and may cause side effects.
Phase II clinical trials determine if the investigational treatment
is effective (American Cancer Society, 2017).
Charleston Laboratories is now centralising its comprehensive acute pain portfolio to treat acute pain and opioid-induced nausea and vomiting, and accelerating the process to bring investigational treatment
CL-108 to market.
It may be premature to ask, but we highlight this investigational treatment
as a notable scientific development that might possibly help us overcome the disease in the long run.
Biogen and Ionis Pharmaceuticals' Phase III study evaluating SPINRAZA (nusinersen), an investigational treatment
for spinal muscular atrophy (SMA), met the primary endpoint at the interim analysis.